Xeris Biopharma Inc.
(XERS)
undefined
undefined%
At close: undefined
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
| Net Income | -62.26M | -94.66M | -94.66M | -122.72M | -91.14M | -60.08M | -26.55M | -13.21M |
| Depreciation & Amortization | 13.16M | 12.67M | 12.67M | 1.88M | 1.47M | 320.00K | 177.00K | 116.00K |
| Stock-Based Compensation | 10.72M | 12.16M | 11.38M | 8.27M | 6.48M | 1.73M | 499.00K | 540.00K |
| Other Working Capital | 9.92M | -9.99M | -9.99M | 19.98M | 7.01M | 345.00K | -140.00K | -32.00K |
| Other Non-Cash Items | -1.10M | 3.52M | 3.52M | 961.00K | 3.10M | 560.00K | 94.00K | 49.00K |
| Deferred Income Tax | -1.25M | -1.42M | -1.42M | 1.11M | 536.00K | -414.00K | - | - |
| Change in Working Capital | -6.29M | -35.15M | -35.15M | 11.85M | -2.80M | 1.61M | 1.12M | -3.58M |
| Operating Cash Flow | -47.02M | -102.89M | -102.89M | -95.53M | -80.56M | -56.28M | -24.66M | -16.09M |
| Capital Expenditures | -2.26M | -524.00K | -524.00K | -1.08M | -377.00K | -1.51M | -700.00K | -35.00K |
| Acquisitions | - | - | 38.47M | 38.47M | 377.00K | - | - | - |
| Purchase of Investments | -43.74M | - | -43.02M | -43.02M | -101.77M | -68.85M | - | - |
| Sales Maturities Of Investments | 40.00M | 34.98M | 34.98M | 103.60M | 74.75M | 2.10M | - | - |
| Other Investing Acitivies | - | 34.98M | 4.55M | -27.03M | -377.00K | -66.75M | - | - |
| Investing Cash Flow | -6.00M | 34.46M | 34.46M | 97.96M | -27.41M | -68.26M | -700.00K | -35.00K |
| Debt Repayment | - | 102.72M | - | 69.75M | 25.00M | 35.00M | - | -32.00K |
| Common Stock Repurchased | -1.01M | -468.00K | -534.00K | -63.00K | - | - | - | - |
| Dividend Paid | - | - | - | - | - | - | - | - |
| Other Financial Acitivies | -604.00K | -4.78M | 781.00K | -9.51M | 55.53M | 4.11M | 35.14M | 3.94M |
| Financial Cash Flow | -1.61M | 127.47M | 127.47M | 27.25M | 126.06M | 128.21M | 35.14M | 3.90M |
| Net Cash Flow | -54.64M | 59.04M | 59.04M | 29.67M | 18.08M | 3.67M | 9.78M | -12.22M |
| Free Cash Flow | -49.29M | -103.42M | -103.42M | -96.62M | -80.94M | -57.79M | -25.36M | -16.12M |